Menu
Not yet recruiting NCT06887465

Non-invasive and Continuous Blood Pressure Monitoring

— Observational Blood Pressure

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-invasive Blood Pressure Monitor.
Who it may be relevant to
Registry conditions: Blood Pressure. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Comparison of Non-Invasive Wearable Sensors to Radial Arterial Catheterization on Human Subjects

Overview

The goal of this observational study is to evaluate the accuracy and reliability of the VeriTrack non-invasive blood pressure monitor compared to radial arterial catheterization in adult surgical patients. The main question it aims to answer is: How well does VeriTrack measure continuous blood pressure compared to an arterial catheter? Researchers will compare VeriTrack readings to arterial line measurements to determine if the VeriTrack provides comparable accuracy and clinical utility. Participants will wear the VeriTrack device during surgery and have a radial arterial catheter placed as part of standard care.

Interventions

  • Device Non-invasive Blood Pressure Monitor
    Application of the VeriTrack non-invasive blood pressure monitor

Primary outcome measures

  • Accuracy of the VeriTrack device in continuous blood pressure monitoring [Time frame: 1-24 hours]
Secondary outcome measures (1)
  • Blood Pressure Change Accuracy [Time frame: 1-24 hours]

Eligibility criteria

Inclusion criteria

  • Patients whose blood pressure will be monitored using an arterial line during their procedure
  • Patients who have a palpable dorsalis pedis pulse

Exclusion criteria

  • Patients who have non-palpable dorsalis pedis pulses
  • Patients whose limbs are inaccessible for placement of Vena Vitals Wearable
  • Patients with known allergy to adhesives and/or silicone

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United States · 1 center
  • Thomas Jefferson University — Philadelphia

Identifiers

NCT: NCT06887465 · VVAL0001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗